SEC Form 4 · accession 0001437749-15-000260
HYPERION THERAPEUTICS INC · HPTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald J Santel
Officer — CEO & President · Director
Period of report
Jan 2, 2015
Accepted (ET)
Jan 5, 2015 · 8:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386858
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 2, 2015 | F | 2,022 | $24.28 | D | 16,478 | D | |
| Common Stock | holding | — | — | — | 10,164 | I | By Donald J. Santel and Kelly L. McGinnis, Trust UA. dated 12/18/08 FBO Margaret Cate Santel |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld by Hyperion to satisfy taxes payable in connection with vesting of previously awarded restricted stock units.